APPLIED AND ENVIRONMENTAL MICROBIOLOGY, May 2002, p. 2095–2100 0099-2240/02/$04.00⫹0 DOI: 10.1128/AEM.68.5.2095–2100.2002 Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Vol. 68, No. 5

MINIREVIEWS Auxotrophic Yeast Strains in Fundamental and Applied Research Jack T. Pronk* Kluyver Laboratory of Biotechnology, Delft University of Technology, 2628 BC Delft, The Netherlands construction of myriads of laboratory strains of S. cerevisiae with various combinations of auxotrophic markers. Upon the completion of the genome sequence of S. cerevisiae, scientists set out to assign biochemical and physiological functions to thousands of newly discovered open reading frames (16). Even a basal understanding of cellular function cannot be based solely on qualitative phenotypic analysis but also requires accurate quantitative approaches (31). These approaches require elimination of experimental “noise” resulting from strain choice or unintended side effects of genetic modifications. In my own research and while serving as an Editorial Board member of this journal, I have frequently struggled with complications arising from the incorrect use of auxotrophic strains and auxotrophy-complementing marker genes in physiological studies on S. cerevisiae and other yeasts. The objective of this minireview is to consider a number of aspects that are relevant for the application of auxotrophic yeast strains in quantitative physiology, functional genome analysis, and industrial applications. Although the focus will be on S. cerevisiae, the general considerations should be applicable to other yeasts and, indeed, to other microorganisms.

Molecular genetic tools have become increasingly important in fundamental and applied yeast research. Genetic modifications, such as the targeted inactivation of genes or their controlled (over)expression from episomal or integrating vectors, require the use of selectable marker genes for efficient detection and selection of transformed cells (4). After genetic modification, marker genes may be applied to counterselect against revertants. Especially during gene expression from episomal vectors, this counterselection is often a prerequisite for avoiding overgrowth of the population with cells that have lost the expression vector (18, 33). Several marker genes used in yeast genetics confer resistance against antibiotics or other toxic compounds (42). Selection for strains that carry such marker genes requires the addition of these toxic compounds to the growth media. In addition to their toxicity, the price of many of these compounds precludes their use in large-scale processes (18). Moreover, even in resistant strains, the presence of antibiotics may affect cellular function. An alternative is the use of marker genes that complement specific nutritional requirements. Some of the most commonly applied marker genes are wildtype alleles of yeast genes that encode key enzymes in the metabolic pathways towards essential monomers used in biosynthesis. An example is the URA3 gene, which encodes orotidine-5⬘-phosphate decarboxylase, an essential enzyme in pyrimidine biosynthesis in Saccharomyces cerevisiae (3). Similarly, the HIS3, LEU2, TRP1, and MET15 marker genes encode essential enzymes for de novo synthesis of the amino acids L-histidine, L-leucine, L-tryptophan, and L-methionine, respectively (4, 8). Use of these genes as markers is restricted to host strains that are auxotrophic for the nutrient in question due to the absence of a functional chromosomal copy of the marker gene. Unless transformed to prototrophy with a functional allele of the marker gene, auxotrophic yeast strains can be propagated only in media that contain the appropriate growth factor(s). This nutritional complementation may be achieved either by including the growth factors in defined synthetic media or by using complex medium components (e.g., yeast extract and peptone) that are rich in the relevant growth factors. The ease with which auxotrophic yeast strains and the corresponding auxotrophy-complementing genes can be manipulated and the low cost of the chemicals involved have contributed to the

APPLICATIONS OF AUXOTROPHIC YEAST STRAINS An important area of application of auxotrophic yeast strains and the corresponding marker genes is the stable maintenance of expression vectors for the high-level production of native or heterologous proteins (18, 33). When a high expression vector copy number is desirable, marker genes with a partially defective promoter may be applied, e.g., the LEU2d marker (14). The rationale behind this approach is that, as the expression of the defective marker gene from each copy is reduced, growth on media that lack the auxotrophically required growth factor will confer a strong selective advantage upon cells with a high copy number of the expression vector. An additional advantage of these “defective” markers is that they may avoid protein-burden effects (39) due to massive overexpression of the marker gene. Both LEU2d and TRP1d markers have been used successfully to obtain high copy numbers of plasmid-borne as well as integrated expression cassettes (29, 30). Another important application of auxotrophic markers is the introduction of knock-out mutations. Targeted inactivation of yeast genes is now performed almost exclusively via the onestep gene deletion method (35). In this approach, a marker gene is equipped with short 5⬘ and 3⬘ sequences that are identical to the sequences flanking the chromosomal sequences that need to be deleted. If auxotrophy complementation is

* Mailing address: Kluyver Laboratory of Biotechnology, Delft University of Technology, Julianalaan 67, 2628 BC Delft, The Netherlands. Phone: 31 15 278 3214. Fax: 31 15 213 3141. E-mail: j.t.pronk 2095




used as the marker system for one-step gene inactivation, the resulting deletion mutant will become prototrophic for the nutrient involved. This change has two consequences. First, the null mutant will have a set of auxotrophic requirements different from that of the original host (see below). Second, the marker gene used for gene inactivation will no longer be available for further genetic modifications. This restriction may be cumbersome if multiple deletions need to be introduced, e.g., during the deletion of large gene families or as part of the construction of null mutants in aneuploid industrial strains. This problem can be bypassed by marker recovery strategies based on site-specific recombination, mediated, for example, by the cre-loxP recombination system of bacteriophage P1 (17, 36). These strategies involve the introduction of flanking repeat sequences at the 5⬘ and 3⬘ ends of the marker gene, which are recognized by a specific recombinase. By introduction of a helper plasmid encoding this recombinase, the integrated copy of the auxotrophy-complementing marker gene is excised, rendering the strain accessible to new rounds of modification with the same marker gene. GENETIC COMPLEMENTATION VERSUS NUTRITIONAL SUPPLEMENTATION The use of auxotrophic strains in physiological studies rests on the (generally implicit) assumption that introduction of the appropriate marker gene results in a situation that is physiologically identical to that in a congenic, prototrophic reference strain. However, this assumption may not hold, especially if marker genes are introduced at high copy numbers. For example, in S. cerevisiae, strains carrying a multicopy plasmid with the LEU2 gene, Leu2p (isopropylmalate dehydrogenase) made up 1 to 2% of the soluble protein (20). In addition to possible specific effects on metabolic regulation, e.g., as a consequence of altered metabolite pools, intracellular overproduction of proteins may lead to nonspecific protein-burden effects (39). Indeed, strain-dependent effects of LEU2 expression from a multicopy vector on the final biomass density in glucose-grown batch cultures have been reported (5). When an auxotrophic strain is complemented by introduction of a single copy of the wild-type allele of the affected gene, as is the case during integrative recombination, no detrimental effects are anticipated, with the exception of effects caused by (extra)chromosomal location. However, after one-step gene inactivation with an auxotrophy-complementing marker gene, the transformed strain has a set of auxotrophies different from that of the original host strain since one of the markers present in the original strain is eliminated by the transformation event. To compensate for this deletion, the auxotrophic host strain must be grown by including the appropriate auxotrophic growth factor in the medium. In a physiological sense, nutritional supplementation may differ strongly from genetic complementation. For example, nutritional and genetic complementation of an S. cerevisiae leu2 null mutant in glucose-grown shakeflask cultures yielded different specific growth rates (Fig. 1). A similar phenomenon was observed in a comparison of nutritional and genetic complementation of a ura3 mutant of a commercial baker’s yeast strain (T. Petit, personal communication). In contrast to genetic complementation, nutritional supplementation requires uptake of the auxotrophically required

FIG. 1. Genetic complementation versus nutritional supplementation. Shown are growth curves of the prototrophic S. cerevisiae strain CEN.PK113-7D (E), the congenic leu2-3 null mutant CEN.PK113-16B (■), and CEN.PK113-16B transformed with the multicopy vector YEPlac181 (15) that carries the wild-type LEU2 allele (䊐). All three strains were grown at 30°C in shake flasks on a defined synthetic medium (47) with 20 g of glucose liter⫺1 as the carbon source. LLeucine was added to the nontransformed CEN.PK113-16B culture at a concentration of 500 mg liter⫺1 (Table 1). Cultures were inoculated from exponentially growing cultures on the same medium. Exponential growth started without a detectable lag phase. Specific growth rates calculated from the exponential growth phase preceding the diauxic shift were 0.40 h⫺1, 0.34 h⫺1, and 0.39 h⫺1, respectively. Data are presented as the average of two independent shake-flask cultures for each strain and, for the points preceding the diauxic shift, differed by less than 4% between the replicate cultures.

compound by the cells and, in the case of uracil, activity of the pyrimidine salvage pathway (24). If these processes exert control over the specific growth rate, nutritional supplementation may result in a lower specific growth rate than genetic restoration to prototrophy. Additionally, inclusion of auxotrophically required compounds in growth media may interfere with the biosynthesis of other essential compounds. For example, unless isoleucine or valine is also added, addition of leucine leads to a reduction of the specific growth rate of wild-type S. cerevisiae on synthetic medium, indicating that leucine modulates the activity and/or expression of enzymes in the biosynthetic pathways towards the other two branched-chain amino acids (28). An elegant demonstration of the impact of nonmatching auxotrophies on growth kinetics is provided by a set of experiments on S. cerevisiae strains in which the HO gene (which has no known cellular role other than mating type switching) was inactivated by replacement with either the antibiotic resistance marker gene kanMX or the HIS3 gene (2). In competition experiments, performed in chemostat cultures grown under several nutrient limitation regimens, the ho⌬::kanMX null mutation did not confer a significant competitive (dis)advantage

VOL. 68, 2002

relative to a congenic strain carrying the wild-type HO allele. However, in histidine-supplemented chemostat cultures, the fitness of congenic HO his3 and ho⌬::HIS3 strains (which had nonmatching auxotrophies) differed strongly. Under glucoselimited growth conditions, the ho⌬::HIS3 strain rapidly outcompeted the histidine-auxotrophic HO his3 strain. Conversely, under ammonia-limited growth conditions, the histidine prototroph disappeared from the mixed culture within 30 generations (2). The dependency of this marker gene effect on growth conditions may be related to nitrogen catabolite repression of amino acid uptake and catabolism in S. cerevisiae (19). Without the kanMX control, the experiments of Baganz et al. (2) might have led to the wrong interpretation that deletion of the HO gene affects growth kinetics in chemostat cultures. Nonmatching auxotrophies also may result in different stoichiometries of biomass and product formation. For example, based on a comparison of strains with nonmatching auxotrophies, it was initially reported that deletion of the ATH1 gene (encoding vacuolar acid trehalase) resulted in increased biomass yields of S. cerevisiae on glucose (22). This was subsequently shown to be due to the introduction of a wild-type allele of URA3 in the ath1 null mutant (7). Effects on growth stoichiometry may reflect energy costs of uptake and incorporation of auxotrophically required nutrients as well as carbon and nitrogen supplementation effects caused by their inclusion in growth media. Especially under anaerobic conditions, inclusion of amino acids in growth media may significantly affect cellular redox balance and product formation (1). This is mainly due to changes in the net production of NADH in amino acid biosynthesis. These changes are reflected in the production of glycerol, which, in anaerobic S. cerevisiae cultures, is the main sink for NADH redox equivalents (1). DESIGN OF SYNTHETIC MEDIA FOR CULTIVATION OF AUXOTROPHIC STRAINS When auxotrophic strains are grown on agar plates for routine qualitative tests or strain maintenance, the concentrations of compounds required for nutritional complementation are not critical. These concentrations are important when quantitative parameters such as specific growth rates and/or biomass yields are determined in liquid media. In such cases, it is undesirable for growth to become limited by the concentration of the auxotrophically required nutrient in the medium. Many standard synthetic medium recipes for cultivation of S. cerevisiae are based on an initial glucose concentration of 20 g liter⫺1. If glucose repression is alleviated by aerobic, glucoselimited cultivation (43) or via genetic modification (13), biomass yields of up to 0.5 g of biomass g of glucose⫺1 can be achieved. In aerobic batch cultures of wild-type S. cerevisiae strains, the typical diauxic growth on glucose and ethanol (formed during the first, respirofermentative, phase of growth) leads to overall biomass yields of ca. 0.4 g g⫺1 (25). Based on these biomass yields and published data on the biomass composition of S. cerevisiae (32), it is straightforward to estimate the minimum requirements for auxotrophically required compounds. As an example, the S. cerevisiae leucine-auxotrophic leu2 null mutants’ requirement for leucine will be discussed. L-Leucine accounts for ca. 10% of the mass of yeast protein, and the protein content of dry yeast biomass is ca. 40% (32).



TABLE 1. Estimated contents of commonly applied auxotrophycomplementing compounds in S. cerevisiae biomass and recommended concentrations for aerobic cultivation of S. cerevisiae on defined media containing 20 g of glucose liter⫺1 Marker gene


Compound required by auxotroph

Content in biomass (g g of biomass⫺1)a

Recommended addition (mg liter⫺1)b

L-Histidine L-Leucine L-Tryptophan L-Methionine

0.010 0.039 0.006 0.007 0.011

125 500 75 100 150



Contents in biomass are estimates based on published data on macromolecular biomass composition, amino acid composition of yeast protein, and G⫹C content (32). b The recommended addition is based on an aerobic biomass yield on glucose of 0.5 g of biomass g of glucose⫺1 and an excess factor of 1.25 for the auxotrophycomplementing compound.

Consequently, a leucine auxotroph will require ca. 40 mg of leucine for the formation of 1 g (dry weight) of yeast biomass. In a medium containing 20 g of glucose per liter, ca. 10 g of biomass can be formed under optimal, aerobic, cultivation conditions (43). To avoid growth limitation by leucine during cultivation of a leucine auxotroph, such a medium should contain at least 400 mg of leucine per liter. This concentration is higher than an experimentally determined value of 240 mg liter⫺1 (5). However, the possibility that growth in the synthetic medium used in this study (5) may have been limited by a nutrient other than glucose or leucine cannot be excluded. The protein content of yeast biomass is dependent on environmental conditions (46). Furthermore, in the example given above, part of the leucine added to the media may be deaminated and decarboxylated via the enzymes of the Ehrlich pathway (12). It therefore seems prudent to maintain an excess factor in the design of media. In Table 1, minimum requirements for nutritional complementation of some commonly applied auxotrophies have been listed and recommendations have been given for media containing 20 g of glucose liter⫺1, based on an excess factor of ca. 25%. Since, under anaerobic conditions, the biomass yield on glucose is ca. fivefold lower than the maximum biomass yield in aerobic cultures (43), these recommended concentrations can be divided by a factor of five for anaerobic cultivation on glucose. In the literature, and even in handbooks for yeast research (34, 37, 40), many instances are encountered in which required auxotrophic nutrients are added at concentrations of 10 to 40 mg liter⫺1. As illustrated in Table 1, this will often result in starvation for—or growth limitation by—the auxotrophically required nutrient. The ensuing metabolic, regulatory, and morphological changes (6, 11) may readily lead to misinterpretation of experimental data. STABILITY OF TRANSFORMED STRAINS AND CROSS-FEEDING When auxotrophy-complementing genes are used as selective markers on episomal expression vectors, the resulting strains should, ideally, be stable in selective media (i.e., media that lack the nutrient required by the corresponding auxotrophic strains). Commonly used complex media for laboratory cultivation of yeasts contain yeast extract and peptone and thus



abound in amino acids and bases. The same holds for many industrial media that are used for large-scale cultivation of yeasts. This normally precludes the use of auxotrophy-complementing marker genes. An elegant system has been developed to allow for the use of the URA3 marker gene even in complex, uracil-containing media. This system is based on inactivation of the FUR1 gene (26). In S. cerevisiae, the essential biosynthetic intermediate UMP (uridine 5⬘-monophosphate) can be synthesized either by de novo biosynthesis via a pathway involving the URA3 gene product (3) or by direct conversion of uracil via the pyrimidine salvage pathway (24). FUR1 encodes uracil phosphoribosyltransferase, a key enzyme in the latter pathway (24). Strains that contain disfunctional chromosomal copies of both FUR1 and URA3 allow for the use of a plasmid-borne URA3 gene as a selectable marker, even in uracil-containing media. This concept has been successfully applied to the stable expression of heterologous proteins in complex media (26, 45). However, prototrophic fur1 strains have a reduced specific growth rate on glucose; this may be a problem in applications that require rapid growth. Although rarely investigated, cross-feeding may be a relevant phenomenon during the cultivation of auxotrophic yeast strains. In some cases, prototrophic strains appear to release either the auxotrophically required nutrient itself or related biosynthetic intermediates that are located downstream from the metabolic lesion in the auxotrophic strain. Even when synthetic and apparently selective media are used, this may allow for the establishment of mixed cultures, in which a subpopulation of auxotrophic strains remains metabolically active. This is exemplified by an experiment in which a leu2 strain of S. cerevisiae, transformed with a LEU2-bearing expression vector, was grown in carbon-limited chemostat cultures on a synthetic medium without leucine. After prolonged cultivation, up to 45% of the population consisted of leucine-auxotrophic cells and low concentrations of leucine were detectable in culture supernatants (27). Therefore, even under apparently selective conditions, it is advisable to check plasmid stability, e.g., by performing plate assays. Cross-feeding of auxotrophic strains is relevant not only when the auxotrophies are employed as selectable markers. It has been proposed that competition experiments with mixed cultures, consisting of large numbers of oligonucleotide-tagged deletion mutants, may be a powerful tool for rapid and quantitative functional analysis of yeast genes (2, 38). However, it is conceivable that in such mixed cultures, in which each deletion mutant makes up only a small fraction of the total population, cross-feeding of metabolic intermediates may hide relevant phenotypes. PHENOTYPE MASKING IN AUXOTROPHIC STRAINS In the assignment of biochemical functions to the 6,281 (predicted) proteins presently listed in the Yeast Protein Database (9, 10), the possibility that many of these proteins have multiple roles in the metabolic and regulatory network of S. cerevisiae must be considered. By altering pools of metabolites, cofactors, and effectors, changes in the expression of a protein can reverberate throughout the metabolic network. If such secondary functions and/or effects involve pathways in which


an auxotrophy-complementing marker gene participates, they may easily go unnoticed in auxotrophic strain backgrounds. An example of phenotype masking by an auxotrophic strain background is provided by a study on a pda1 null mutant (48). When the PDA1 gene, encoding an essential subunit of the yeast pyruvate-dehydrogenase complex, was deleted in the prototrophic strain T2-3D, this resulted in a substantial reduction of the maximum specific growth rate on glucose. This effect was entirely absent in the M5 strain background that carries a defective leu2 allele. This strain-dependent phenotype was shown to be due to a partial leucine requirement induced by the pda1 mutation. This interesting phenotype, which probably results from an altered intramitochondrial acetyl-coenzyme A/coenzyme A ratio (48), would have gone entirely unnoticed if the studies had been confined to a leu2 strain background— which by definition has to be provided with leucine. Similarly, the requirement of S. cerevisiae zwf1 null mutants for methionine (ZWF1 encodes glucose-6-phosphate dehydrogenase [41]) might have gone unnoticed if the strain background have been auxotrophic for methionine. OUTLOOK Auxotrophic yeast strains continue to be convenient platforms for applied research, especially in the field of heterologous gene expression. However, for optimal application of these marker genes, possible drawbacks (cross-feeding, metabolic consequences resulting from high copy numbers of the marker gene) continue to deserve experimental attention. As the data intensity and costs of experimental biology increase, it becomes ever more important to eliminate factors that may interfere with data interpretation. As discussed in this minireview, use of auxotrophic strains may tremendously complicate the interpretation of experimental data in functional genomics, physiology, and metabolic engineering. Since good alternative marker genes and marker-rescue systems are available, it is advisable to avoid the use of auxotrophic strains in such research—unless the auxotrophy itself is the subject of study. When auxotrophic strains are used for reasons of practicality or economy, comparison of strains with nonmatching auxotrophies should be avoided at all times and auxotrophically required nutrients should be provided in amounts that prevent them from becoming growth limiting (Table 1). Even when prototrophic strains are used, great care should be exercised in the design of synthetic growth media in order to avoid “hidden” nutrient limitations. I stress that, since nutritional requirements of microorganisms vary as a function of growth conditions and genetic background, it is essential to experimentally verify which nutrient limits biomass formation even when prototrophic strains are used. It becomes ever clearer that the physiological properties of different S. cerevisiae strains can differ greatly (23, 44). At a time when public domain databases have become vital tools for studies on popular model organisms such as S. cerevisiae, it is important to minimize the confusion that may arise from comparison of quantitative data from different genetic backgrounds. It is therefore worthwhile to strive for a limited number of well-defined and experimentally accessible reference strains. Based on a comparison of four candidate strains, a consortium of European yeast research groups has recently

VOL. 68, 2002


proposed prototrophic strains of the CEN.PK family of S. cerevisiae as a useful platform for integrated genetic and physiological studies on this yeast (43). Similarly, the prototrophic strain CBS2359 has been proposed as a reference strain for the yeast Kluyveromyces lactis (21, 49). Clearly, using standard strains to compile a reference set of quantitative data should not lead researchers to extrapolate “strain behavior” to “species behavior” or to neglect biodiversity within and among species as a source of scientific inspiration and information.

18. 19. 20. 21.



I thank Matthijs Groothuizen for doing the experiments shown in Fig. 1 and Marijke Luttik, Matthew Piper, and Ton van Maris for critical reading of the manuscript.




1. Albers, E., C. Larsson, G. Liden, C. Niklasson, and L. Gustafsson. 1996. Influence of the nitrogen source on Saccharomyces cerevisiae anaerobic growth and product formation. Appl. Environ. Microbiol. 62:3187–3195. 2. Baganz, F., A. Hayes, D. Marren, D. C. J. Gardner, and S. G. Oliver. 1997. Suitability of replacement markers for functional analysis studies in Saccharomyces cerevisiae. Yeast 13:1563–1573. 3. Boeke, J. D., F. LaCroute, and G. R. Fink. 1984. A positive selection for mutants lacking orotidine-5⬘-phosphate decarboxylase activity in yeast; 5-fluoro-orotic acid resistance. Mol. Gen. Genet. 197:345–346. 4. Botstein, D., and R. W. Davis. 1982. Principles and practice of recombinant DNA research with yeast, p. 607–636. In J. N. Strathern, E. W. Jones, and J. R. Broach (ed.), The molecular biology of the yeast Saccharomyces cerevisiae. Metabolism and gene expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 5. Çakar, Z. P., U. Sauer, and J. E. Bailey. 1999. Metabolic engineering of yeast: the perils of auxotrophic hosts. Biotechnol. Lett. 21:611–616. 6. Çakar, Z. P., U. Sauer, J. E. Bailey, M. Muller, T. Walliman, and U. Schlattner. 2000. Vacuolar morphology and cell cycle distribution are modified by leucine limitation in auxotrophic Saccharomyces cerevisiae. Biol. Cell 92:629–637. 7. Chopra, R., V. M. Sharma, and K. Ganesan. 1999. Elevated growth of Saccharomyces cerevisiae null mutants on glucose is an artifact of nonmatching auxotrophies of mutant and reference strains. Appl. Environ. Microbiol. 65:2267–2268. 8. Cost, G. J., and J. D. Boeke. 1996. A useful colony colour phenotype associated with the yeast selectable/counterselectable marker MET15. Yeast 12:939–941. 9. Costanzo, M. C., J. D. Hogan, M. E. Cusick, B. P. Davis, A. M. Fancher, P. E. Hodges, P. Kondu, C. Lengieza, J. E. Lew-Smith, C. Lingner, K. J. RobergPerez, M. Tillberg, J. E. Brooks, and J. I. Garrels. 2000. The Yeast Proteome Database (YPD) and Caenorhabditis elegans Proteome Database (WormPD): comprehensive resources for the organization and comparison of model organism protein information. Nucleic Acids Res. 28:73–76. 10. Costanzo, M. C., M. E. Crawford, J. E. Hirschman, J. E. Kranz, P. Olsen, L. S. Robertson, M. S. Skrzypek, B. R. Braun, K. L. Hopkins, P. Kondu, C. Lengieza, J. E. Lew-Smith, M. Tillberg, and J. I. Garrels. 2001. YPD™, PombePD™, and WormPD™: model organism volumes of the BioKnowledge™ library, an integrated resource for protein information. Nucleic Acids Res. 29:75–79. 11. De Winde, J. H., J. M. Thevelein, and J. Winderickx. 1997. From feast to famine: adaptation to nutrient limitation in yeast, p. 7–52. In S. Hohmann and W. H. Mager (ed.), Yeast stress responses. R.G. Landes Co., Austin, Tex. 12. Dickinson, J. R. 2000. Pathways of leucine and valine catabolism in yeast. Methods Enzymol. 324:80–92. 13. Diderich, J. A., L. M. Raamsdonk, A. L. Kruckeberg, J. A. Berden, and K. van Dam. 2001. Physiological properties of Saccharomyces cerevisiae from which hexokinase II has been deleted. Appl. Environ. Microbiol. 67:1587– 1593. 14. Erhart, E., and C. P. Hollenberg. 1983. The presence of a defective LEU2 gene on 2␮m DNA recombinant plasmids of Saccharomyces cerevisiae is responsible for curing and high copy number. J. Bacteriol. 156:625–635. 15. Gietz, R. D., and A. Sugino. 1988. New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene 74:527–534. 16. Goffeau, A., B. G. Barrell, H. Bussey, R. W. Davis, B. Dujon, H. Feldmann, F. Galibert, J. D. Hoheisel, C. Jacq, M. Johnston, E. J. Louis, H. W. Mewes, Y. Murakami, P. Philippsen, H. Tettelin, and S. G. Oliver. 1997. Life with 6000 genes. Science 275:1051–1052. 17. Güldener, U., S. Heck, T. Fiedler, J. Beinhauer, and J. H. Hegemann. 1996.

25. 26.


28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43.


A new efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids Res. 24:2519–2524. Hensing, M. A., R. Rouwenhorst, J. J. Heijnen, J. P. van Dijken, and J. T. Pronk. 1995. Physiological and technological aspects of large-scale heterologous-protein production with yeasts. Antonie Leeuwenhoek 67:261–279. Hofman-Bang, J. 1999. Nitrogen catabolite repression in Saccharomyces cerevisiae. Mol. Biotechnol. 12:35–73. Hsu, Y. P., and G. B. Kohlhaw. 1982. Overproduction and control of the LEU2 gene product, ␤-isopropylmalate dehydrogenase, in transformed yeast strains. J. Biol. Chem. 257:39–41. Kiers, J., A. M. Zeeman, M. Luttik, C. Thiele, J. I. Castrillo, H. Y. Steensma, J. P. van Dijken, and J. T. Pronk. 1998. Regulation of alcoholic fermentation in batch and chemostat cultures of Kluyveromyces lactis CBS 2359. Yeast 14:459–469. Kim, J., P. Alizadeh, T. Harding, A. Hefner-Gravink, and D. J. Klionsky. 1996. Disruption of the yeast ATH1 gene confers better survival after dehydration, freezing, and ethanol shock: potential commercial applications. Appl. Environ. Microbiol. 62:1563–1569. Klein, C. J. L., L. Olsson, B. Ronnow, J. D. Mikkelsen, and J. Nielsen. 1996. Alleviation of glucose repression of maltose metabolism by MIG1 disruption in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 62:4441–4449. Kurtz, J. E., F. Exinger, P. Erbs, and R. Lund. 1999. New insights into the pyrimidine salvage pathway of Saccharomyces cerevisiae: requirement of six genes for cytidine metabolism. Curr. Genet. 36:130–136. Locher, G., U. Hahnemann, B. Sonnleitner, and A. Fiechter. 1993. Automatic bioprocess control. 4. A prototype batch of Saccharomyces cerevisiae. J. Biotechnol. 29:57–74. Loison, G., M. Nguyen-Juilleret, S. Alouani, and M. Marquet. 1986. Plasmidtransformed ura3 fur1 double mutants of Saccharomyces cerevisiae: an autoselection system applicable to the production of foreign proteins. Bio/ Technology 4:433–438. Meinander, N. Q., and B. Hahn-Hägerdal. 1997. Fed-batch xylitol production with two recombinant Saccharomyces cerevisiae strains expressing XYL1 at different levels, using glucose as a cosubstrate: a comparison of production parameters and strain stability. Biotechnol. Bioeng. 54:391–394. Niederberger, P., G. Miozzari, and R. Hütter. 1981. Biological role of the general control of amino acid biosynthesis in Saccharomyces cerevisiae. Mol. Cell. Biol. 1:584–593. Nielsen, T. L., S. Holmberg, and J. G. L. Petersen. 1990. Regulated overproduction and secretion of yeast carboxypeptidase-Y. Appl. Microbiol. Biotechnol. 33:307–312. Nieto, A., J. A. Prieto, and P. Sanz. 1999. Stable high-copy-number integration of Aspergillus oryzae ␣-amylase cDNA in an industrial baker’s yeast strain. Biotechnol. Prog. 15:459–466. Oliver, S. G., M. K. Winson, D. B. Kell, and F. Baganz. 1998. Systematic functional analysis of the yeast genome. Trends Biotechnol. 16:373–378. Oura, E. 1972. The effect of aeration on the growth energetics and biochemical composition of baker’s yeast. Ph.D. thesis, University of Helsinki, Finland. Romanos, M. A., C. A. Scorer, and J. J. Clare. 1992. Foreign gene expression in yeast: a review. Yeast 8:423–488. Rose, M. D., F. Winston, and P. Hieter. 1990. Methods in yeast genetics: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. Rothstein, R. 1991. Targeting, disruption, replacement and allele rescue: integrative transformation in yeast. Methods Enzymol. 194:281–301. Sauer, B. 1987. Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 7:2087– 2096. Sherman, F. 1991. Getting started with yeast. Methods Enzymol. 194:3–21. Shoemaker, D. D., D. A. Lashkari, D. Morris, M. Mittmann, and R. W. Davis. 1996. Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nat. Genet. 14:450–456. Snoep, J. L., L. P. Yomano, H. V. Westerhoff, and L. O. Ingram. 1995. Protein burden in Zymomonas mobilis: negative flux and growth control due to overproduction of glycolytic enzymes. Microbiology 141:2329–2337. Spencer, J. F. T., and D. M. Spencer. 1996. Maintenance and culture of yeasts, p. 5–16. In I. H. Evans (ed.), Yeast protocols. Humana Press, Totowa, N.J. Thomas, D., H. Cherest, and Y. Surdin-Kerjan. 1991. Identification of the structural gene for glucose-6-phosphate dehydrogenase in yeast. Inactivation leads to a nutritional requirement for organic sulfur. EMBO J. 10:547–553. Van den Berg, M. A., and H. Y. Steensma. 1997. Expression cassettes for formaldehyde and fluoroacetate resistance, two dominant markers in Saccharomyces cerevisiae. Yeast 13:551–559. Van Dijken, J. P., J. Bauer, L. Brambilla, P. Duboc, J. M. Francois, C. Gancedo, M. L. F. Giuseppin, J. J. Heijnen, M. Hoare, H. C. Lange, E. A. Madden, P. Niederberger, J. Nielsen, J. L. Parrou, T. Petit, D. Porro, M. Reuss, N. van Riel, M. Rizzi, H. Y. Steensma, C. T. Verrips, J. Vindeløv, and J. T. Pronk. 2000. An interlaboratory comparison of physiological and genetic properties of four Saccharomyces cerevisiae strains. Enzyme Microb. Technol. 26:706–714.



44. Van Hoek, P., J. P. van Dijken, and J. T. Pronk. 2000. Regulation of fermentative capacity and levels of glycolytic enzymes in chemostat cultures of Saccharomyces cerevisiae. Enzyme Microb. Technol. 26:724–736. 45. Van Zyl, W. H., A. Eliasson, T. Hobley, and B. Hahn-Hägerdal. 1999. Xylose utilization by recombinant strains of Saccharomyces cerevisiae on different carbon sources. Appl. Microbiol. Biotechnol. 52:829–833. 46. Verduyn, C. 1991. Physiology of yeasts in relation to growth yields. Antonie Leeuwenhoek 60:325–353. 47. Verduyn, C., E. Postma, W. A. Scheffers, and J. P. van Dijken. 1992. Effect

APPL. ENVIRON. MICROBIOL. of benzoic acid on metabolic fluxes in yeasts: a continuous-culture study on the regulation of respiration and alcoholic fermentation. Yeast 8:501–517. 48. Wenzel, T. J., M. A. van den Berg, W. Visser, J. A. van den Berg, and H. Y. Steensma. 1992. Characterization of Saccharomyces cerevisiae mutants lacking the E1␣ subunit of the pyruvate dehydrogenase complex. Eur. J. Biochem. 209:697–705. 49. Wésolowski-Louvel, M., K. D. Breunig, and H. Fukuhara. 1996. Kluyveromyces lactis, p. 139–202. In K. Wolf (ed.), Non-conventional yeasts in biotechnology. Springer-Verlag, Berlin, Germany.


tion for strains that carry such marker genes requires the ad- dition of ... An alternative is the use of marker .... medium (47) with 20 g of glucose literJ1 as the carbon source. L- ... stoichiometry may reffect energy costs of uptake and incorpo-.

77KB Sizes 0 Downloads 70 Views